Equity Transactions (Details Narrative) - USD ($)			3 Months Ended
	Feb. 02, 2021	Jul. 02, 2020	Sep. 30, 2021	Sep. 30, 2020	Feb. 08, 2021	Jul. 01, 2020	Jun. 30, 2020
Common stock issued during period for consulting services, shares			35,000
Common stock issued during period for acquisition value			$ 175,000
Common stock shares issued				83,334
Sale of common stock to underwriters			15,711,339		500,000		15,262,394
Gross proceeds from sale of stocks	$ 50,000
Common stock shares authorized			100,000,000				100,000,000
Common stock shares par value			$ 0.001				$ 0.001
Common stock shares outstanding			15,711,339				15,262,394
Preferred stock shares issued			500,000				500,000
Preferred stock shares authorized			100,000,000				100,000,000
Preferred stock shares authorized, par value			$ 0.001				$ 0.001
Issuance of common stock for acquisition of Infusionz, amount			$ 1,764,876	$ 340,000
Convertible Preferred Stock [Member]
Preferred stock convertible into shares of common stock ratio	preferred stock is convertible into the Company’s common stock at a ratio of 1.8 shares of preferred stock for a single share
Board of Directors [Member]
Common stock shares par value			$ 0.05
Preferred stock shares issued			500,000
Preferred stock shares authorized			1,000,000
Preferred stock shares authorized, par value			$ 0.001
VitaMedica [Member]
Common stock issued during period for acquisition value			$ 482,000
Common stock issued during period for acquisition			100,000
Infusionz [Member] | Common Stocks [Member]
Common stock issued during period for acquisition value			$ 1,764,876
Common stock issued during period for acquisition			306,945
Issuance of common stock for acquisition of Infusionz, shares				222,223
Issuance of common stock for acquisition of Infusionz, amount				$ 340,000
Trunano Labs, Inc. Common Stock [Member] | July 1, 2020 [Member]
Common stock issued during period for acquisition value			$ 127,500
Common stock shares issued			270,270			7,261,261
Minority interest			$ 1,277,778
Convertion of shares into common stocks noncontrolling shareholders		1,761,261	1,761,261
Outstanding stock conversion		1,277,778	1,277,778
Common stock, percentage of outstanding shares		10.80%	10.80%
Common stock shares authorized			5,770,270			10,000,000
Cash proceeds			$ 300,000
Common stock shares par value						$ 0.001
Common stock shares outstanding						7,261,261
FinderFee [Member]
Common stock issued during period for acquisition value			$ 33,740
Common stock issued during period for acquisition			7,000